Effect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumors
- 1 August 2004
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 72 (2), 221-230
- https://doi.org/10.1016/j.radonc.2004.05.005
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Disparate effects of endostatin on tumor vascular perfusion and hypoxia in two murine mammary carcinomasInternational Journal of Radiation Oncology*Biology*Physics, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Tumor Vessel Development and Maturation Impose Limits on the Effectiveness of Anti-Vascular TherapyThe American Journal of Pathology, 2003
- Effect of the vascular endothelial growth factor receptor‐2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude miceInternational Journal of Cancer, 2002
- Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosisBritish Journal of Cancer, 2002
- Effects of Radiation on Tumor Intravascular Oxygenation, Vascular Configuration, Development of Hypoxia, and Clonogenic SurvivalRadiation Research, 2001
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesisNature Cell Biology, 2000
- Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastasesCancer, 2000
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurementsBritish Journal of Cancer, 1999